Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study

Br J Haematol. 2019 Oct;187(1):e4-e7. doi: 10.1111/bjh.16121. Epub 2019 Aug 1.
No abstract available

Keywords: Myelodysplastic syndrome; androgen; danazol; lower-risk; oxymetholone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Androgens / therapeutic use*
  • Danazol / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / drug therapy*
  • Oxymetholone / therapeutic use
  • Retrospective Studies
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology
  • Treatment Outcome
  • Young Adult

Substances

  • Androgens
  • Oxymetholone
  • Danazol